Amir Halkin, MD

Clinical Outcomes following Percutaneous Coronary Intervention with Drug-Eluting vs. Bare-Metal Stents in Dialysis Patients

08/01/2008

Amir Halkin , MD;

Faith Selzer ;

Oscar Marroquin , MD;

Katherine Detre ;

Howard A. Cohen , MD;

Warren K. Laskey , MD;

Late mortality rates following percutaneous coronary intervention (PCI) among dialysis patients markedly exceed those in patients without end-stage renal disease,1,2 and data preceding the approval and widespread use of drug-eluting stents...

Late mortality rates following...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

Generational Differences in Outcomes of Self-Expanding Valves for Transcatheter Aortic Valve Replacement

04/01/2022

Shmuel Banai , MD;

Haim Danenberg , MD;

Aviram Hochstadt , MD;

Itamar Loewenstein , MD;

David Zahler , MD;

Ariel Finkelstein , MD;

Hana Vaknin-Assa , MD;

Yan Topilsky , MD;

Katia Orvin , MD;

Maayan Konigstein , MD;

Shmuel Bazan , MD;

David Planner , MD;

Arie Steinvil , MD;

Amir Halkin , MD;

Abid R. Assali , MD;

Victor Guetta , MD;

Ran Kornowski , MD;

Israel M. Barbash , MD;

Amit Segev , MD;

The Medtronic Evolut Pro valve (EPV) is a new-generation self-expanding valve (SEV), particularly designed to reduce paravalvular leak (PVL) rates in transcatheter aortic valve replacement (TAVR). We aimed to compare the safety and efficacy...

The Medtronic Evolut Pro valve...

04/01/2022

Journal of Invasive Cardiology